USA Financial Formulas’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$530 Sell
1
-1
-50% -$462 ﹤0.01% 381
2026
Q1
$960 Hold
2
﹤0.01% 334
2025
Q4
$1.12K Buy
+2
New +$1.14K ﹤0.01% 295
2021
Q4
Sell
-326
Closed -$62K 451
2021
Q3
$62K Buy
+326
New +$59.5K 0.06% 182

Other funds holding MEDP

USA Financial Formulas's MEDP Position: Q2 2026 in Review

USA Financial Formulas reduced its Medpace (MEDP) stake by 50% in Q2 2026, selling an estimated $462 and leaving 1 share worth $530. The position accounts for ﹤0.01% of the portfolio, ranked #381.

USA Financial Formulas first reported a position in MEDP in Q3 2021 and has held it in 4 quarters since. The position peaked at $62K in Q3 2021. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • USA Financial Formulas held 1 share of Medpace worth $530 as of Q2 2026.
  • USA Financial Formulas sold 1 Medpace share in Q2 2026, an estimated $462.
  • Medpace made up ﹤0.01% of USA Financial Formulas's portfolio in Q2 2026, its #381 holding.
  • USA Financial Formulas first reported a position in Medpace in Q3 2021 and has held it in 4 quarters since.
  • USA Financial Formulas's Medpace position peaked at $62K in Q3 2021.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.